Variables | Sporadic (n = 18) | UC (n = 18) | P-value |
---|---|---|---|
Age at surgery (years) | 52 (30–73) | 51 (31–68) | 0.866 |
Sex | Â | Â | 0.735 |
 Male | 7 (38.9%) | 8 (44.4%) |  |
 Female | 11 (61.1%) | 10 (55.6%) |  |
BMI (kg/m2) | 23.23 ± 3.36 | 22.38 ± 1.47 | 0.328 |
Stage | Â | Â | 0.593 |
 1 | 4 (22.2%) | 5 (27.8%) |  |
 2 | 9 (50%) | 6 (33.3%) |  |
 3 | 5 (27.8%) | 7 (38.9%) |  |
Adjuvant chemotherapy | Â | Â | 1.0 |
 Yes | 12 (66.7%) | 12 (66.7%) |  |
 No | 6 (33.3%) | 6 (33.3%) |  |
Histology | Â | Â | 0.388 |
 WD | 3 (16.7%) | 5 (27.8%) |  |
 MD | 13 (72.2%) | 9 (50%) |  |
 PD | 2 (11.1%) | 4 (22.2%) |  |
Carcinoembryonic antigen (CEA) | 2.27 ± 2.28 | 2.55 ± 1.79 | 0.684 |
Location | Â | Â | 1.0 |
 Rectum | 3 (16.7%) | 3 (16.7%) |  |
 Colon | 15 (83.3%) | 15 (83.3%) |  |